ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 056,39
0,44%
DAX
18 498,38
0,32%
Brent Oil
83,56
0,84%
Bitcoin
61 529,87
-1,29%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) Actualités

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:ABT
DateHeureSourceTitreSymboleSociété
08/05/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
08/05/202400h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
29/04/202415h00PR Newswire (US)Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneeNYSE:ABTAbbott Laboratories
17/04/202417h37IH Market NewsAbbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year GuidanceNYSE:ABTAbbott Laboratories
17/04/202413h30PR Newswire (US)Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance RangesNYSE:ABTAbbott Laboratories
17/04/202412h59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:ABTAbbott Laboratories
03/04/202413h12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:ABTAbbott Laboratories
02/04/202415h00PR Newswire (US)Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
01/04/202415h00PR Newswire (US)Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's BedsideNYSE:ABTAbbott Laboratories
27/03/202421h30PR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
19/03/202413h00PR Newswire (Canada)Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation SystemNYSE:ABTAbbott Laboratories
19/03/202413h00PR Newswire (Canada)Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au mondeNYSE:ABTAbbott Laboratories
06/03/202415h00PR Newswire (US)Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 DiabetesNYSE:ABTAbbott Laboratories
16/02/202422h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ABTAbbott Laboratories
16/02/202416h19PR Newswire (US)Abbott Declares 401st Consecutive Quarterly DividendNYSE:ABTAbbott Laboratories
14/02/202400h47PR Newswire (US)FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
13/02/202422h55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ABTAbbott Laboratories
05/02/202411h31IH Market NewsSantander’s Stock Declines Amid Sanctions Evasion Scandal, Boeing 737 MAX Delivery Challenges, and MoreNYSE:ABTAbbott Laboratories
01/02/202415h00PR Newswire (US)New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate AgainNYSE:ABTAbbott Laboratories
31/01/202415h00PR Newswire (US)Abbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss JourneyNYSE:ABTAbbott Laboratories
29/01/202422h10Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
25/01/202415h00PR Newswire (US)Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+NYSE:ABTAbbott Laboratories
25/01/202412h25IH Market NewsWall Street Highlights: Nokia’s Margins Surprise, FAA Halts Boeing Production Expansion, and MoreNYSE:ABTAbbott Laboratories
24/01/202414h19Dow Jones NewsAbbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid TestsNYSE:ABTAbbott Laboratories
24/01/202413h30PR Newswire (US)Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial OutlookNYSE:ABTAbbott Laboratories
24/01/202412h06IH Market NewsWall Street Highlights: eBay Slashes 9% of Workforce, SAP to Reduce 8,000 Positions, and MoreNYSE:ABTAbbott Laboratories
18/01/202415h48Dow Jones NewsAbbott's Volt PFA System Used in Procedures for Patients with Abnormal Heart RhytmsNYSE:ABTAbbott Laboratories
18/01/202415h00PR Newswire (US)Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsNYSE:ABTAbbott Laboratories
08/01/202414h00Business WireTandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus SensorNYSE:ABTAbbott Laboratories
03/01/202415h00PR Newswire (US)Abbott Hosts Conference Call for Fourth-Quarter EarningsNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT

Dernières Valeurs Consultées

EU
RI
Pernod Ricard
EU
BEL20
Bel 20
EU
LR
Legrand
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
EU
GLE
Societe Generale
COIN
ETHUSD
Ethereum
EU
EN
Bouygues
EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés